Access to Publicly Funded Methadone Maintenance Treatment in Two Western States

Journal of Behavioral Health Services and Research

Volumn 31, Issue 2, 2004, Pages 164-177

  Deck, Dennis ^a   Carlson, Matthew J ^b  

^a RMC RESEARCH CORPORATION   (United States)

^b PORTLAND STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHADONE;

ARTICLE; FINANCIAL MANAGEMENT; HEALTH CARE ACCESS; HOMELESSNESS; HUMAN; INCOME; LEGAL ASPECT; LOGISTIC REGRESSION ANALYSIS; MAINTENANCE THERAPY; MEDICAID; MULTIPLE DRUG ABUSE; OPIATE ADDICTION; PATIENT REFERRAL; UNITED STATES;

EID: 1942533685     PISSN: 10943412     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf02287379     Document Type: Article

References (28)

1. National Institutes of Health, National Consensus Development Panel on Effective Medical Treatment of Opiate Addiction. Effective medical treatment of opiate addiction. Journal of the American Medical Association. 1998;280(22):1936-1943.
2. Substance Abuse and Mental Health Services Administration. Treatment Episode Data Set (TEDS) 1993-1998: National Admissions to Substance Abuse Treatment Services. Rockville, Md: Substance Abuse & Mental Health Services Administration; 2000. DHHS Publication (SMA)00-3465.
3. Executive Office of the President, Office of National Drug Control Policy. Policy Paper: Opioid Agonist Treatment. Washington, DC: Executive Office of the President; 1999.
4. Lewis DC. Access to narcotic addiction treatment and medical care: prospects for the expansion of methadone maintenance treatment. Journal of Addictive Diseases. 1999;18(2):5-21.
5. Marsch LA. The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior, and criminality: a meta-analysis. Addiction. 1998;93(4):515-532.
6. Marsden J, Gossop M, Farrell M, et al. Opioid substitution: critical issues and future directions. Journal of Drug Issues. 1998;28(1):243-264.
7. Ward J, Hall W, Mattick RP. Role of maintenance treatment in opioid dependence. The Lancet. 1999;353:221-226.
8. Weinrich M, Stuart M. Provision of methadone treatment in primary care medical practices: review of the Scottish experience and implications for US policy. Journal of the American Medical Association. 2000;283(10):1343-1348.
9. McCarty D, Frank RG, Denmead GC. Methadone maintenance and state Medicaid managed care programs. The Milbank Quarterly. 1999;77(3):341-362.
10. Deck DD, McFarland BH, Titus JM, et al. Access to substance abuse treatment services under the Oregon Health Plan. Journal of the American Medical Association. 2000;284(16):2093-2099.
11. Farabee D, Leukefeld CG, Hays L. Accessing drug abuse treatment: perceptions of out-of-treatment injectors. Journal of Drug Issues. 1998;28(2):381-394.
12. Greenfield L, Brady JV, Besteman KJ, et al. Patient retention in mobile and fixed-site methadone maintenance treatment. Drug and Alcohol Dependence. 1996;42(2):125-131.
13. Substance Abuse and Mental Health Services Administration. SAMHSA approves accrediting organizations for methadone treatment programs. 2002. Available at: www.health.org/newsroom/releases/2002/Jan02/3.htm/. Accessed May 16, 2002.
14. Zarkin GA, Dunlap LJ. Implication of managed care for methadone treatment: findings from 5 case studies in New York State. Journal of Substance Abuse Treatment. 1999;17:25-35.
15. Tsogia D, Copello A, Orford J. Entering treatment for substance abuse: a review of the literature. Journal of Mental Health. 2001;10(5):481-499.
16. Shah NG, Celentano DD, Vlahov D, et al. Correlates of enrollment in methadone maintenance programs differ by HIV serostatus. AIDS. 2000;14(13):2035-2043.
17. Maddux JF, Desmond DP. Outcomes of methadone maintenance one year after admission. Journal of Drug Issues. 1997;27(2):225-238.
18. Kwiatkowski CF, Booth RE, Lloyd LV. The effects of offering free treatment to street-recruited opioid injectors. Addiction. 2000;95(5):697-704.
19. Hser YI, Maglione M, Polinsky ML, et al. Predicting drug treatment entry among treatment seeking individuals. Journal of Substance Abuse Treatment. 1998;15(3):213-220.
20. Andersen RM. Revisiting the behavioral model and access to medical care: does it matter? Journal of Health and Social Behavior. 1995;36(1):1-10.
21. Office of Alcohol and Drug Abuse Programs. Chemical Dependency Placement, Continued Stay and Discharge Criteria: Adult. Salem, Ore: Office of Alcohol & Drug Abuse Programs; 1995.
22. Deck DD, Gabriel RM, Knudsen J, et al. Impact of client placement criteria on substance abuse treatment under the Oregon Health Plan. Journal of Addictive Diseases. In press.
23. Office of Medical Assistance Programs, Oregon Department of Human Resources. The Oregon Medicaid Reform Demonstration: A Waiver Amendment to Add Mental Health and Chemical Dependency Services to the Demonstration. Salem, Ore: Office of Medical Assistance Programs; 1994.
24. Aday LA, Andersen RM. A framework for the study of access to medical care. Health Services Research. 1974;9:208-220.
25. Gelberg L, Andersen RM, Leake BD. The behavioral model for vulnerable populations: application to medical care use and outcomes for homeless people. Health Services Research. 2000;34(6):1273-1302.
26. Center for Substance Abuse Treatment. Improving Substance Treatment: The National Treatment Plan Initiative. Rockville, Md: Center for Substance Abuse Treatment, Substance Abuse & Mental Health Administration, Dept. of Health & Human Services; 2000.
27. Deck DD, McFarland BH. Use of substance abuse treatment services before and after Medicaid managed care. Psychiatric Services. 2002;53(7):802.
28. Merrill, JO. Policy progress for physician treatment of opiate addiction. Journal of General Internal Medicine. 2002;17:361-368.